Skip to Main Content

Paper Details

IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma.
Sci Rep
21
2016
IGF, IGF1, IGF1R, IGFBP3, MMP, MYC, MYC amplified medulloblastoma, MYC amplified medulloblastoma cells, Metastatic Medulloblastoma, PAI-1, TIMP1, leptomeningeal cells, medulloblastoma, meningothelial cells, metastatic MYC amplified medulloblastoma, metastatic medulloblastoma, patients, tPA
Author NameAffiliation
Matthew N SvalinaChildren's Cancer Therapy Development Institute
Matthew N SvalinaChildren's Cancer Therapy Development Institute
Ken KikuchiOregon Health &Science University
Ken KikuchiOregon Health &Science University
Jinu AbrahamOregon Health &Science University
Jinu AbrahamOregon Health &Science University
Monika A DavareOregon Health &Science University
Monika A DavareOregon Health &Science University
Joel E MichalekUniversity of Texas Health Science Center
Joel E MichalekUniversity of Texas Health Science Center
Noah E BerlowChildren's Cancer Therapy Development Institute
Noah E BerlowChildren's Cancer Therapy Development Institute
Nathan R SeldenOregon Health &Science University
Darell D BignerPediatric Brain Tumor Foundation Institute at Duke, Duke University Medical Center
Kellie J NazemiOregon Health &Science University
Christopher L CorlessOregon Health &Science University
Atiya MansoorOregon Health &Science University
Atiya MansoorOregon Health &Science University
Brian P RubinTaussig Cancer Center and Lerner Research Institute, Cleveland Clinic Foundation
Brian P RubinTaussig Cancer Center and Lerner Research Institute, Cleveland Clinic Foundation
Charles KellerChildren's Cancer Therapy Development Institute
Charles KellerChildren's Cancer Therapy Development Institute
  • 1 - 22

Datasets

Release 1.2